Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Carter's
CRI
$1.42B
| $10.7M | ﹤0.01% |
196,721
+113,884
| +137% | +$6.52M |
|
2877
Grand Canyon Education
LOPE
$3.76B
| $10.7M | ﹤0.01% |
65,027
+18,297
| +39% | +$2.8M |
|
2878
iShares Biotechnology ETF
IBB
$9.73B
| $10.6M | ﹤0.01% |
+80,477
| New | +$11.3M |
|
2879
PUT
Axcelis
ACLS
$4.33B
| $10.6M | ﹤0.01% |
152,200
-118,700
| -44% | -$9.86M |
|
2880
Nabors Industries
NBR
$1.39B
| $10.6M | ﹤0.01% |
185,724
-5,822
| -3% | -$413K |
|
2881
Arhaus
ARHS
$1.39B
| $10.6M | ﹤0.01% |
1,129,495
+736,506
| +187% | +$7.22M |
|
|
NNE
2882
PUT
Nano Nuclear Energy
NNE
$1.06B
| $10.6M | ﹤0.01% |
+426,000
| New | +$9.67M |
|
|
CVSA
2883
Covista Inc
CVSA
$4.49B
| $10.6M | ﹤0.01% |
+116,725
| New | +$9.76M |
|
2884
CALL
Check Point Software Technologies
CHKP
$13.4B
| $10.5M | ﹤0.01% |
56,500
+6,700
| +13% | +$1.26M |
|
2885
CALL
Ralph Lauren
RL
$23.2B
| $10.5M | ﹤0.01% |
45,600
-62,900
| -58% | -$13.4M |
|
2886
Hilltop Holdings
HTH
$2.27B
| $10.5M | ﹤0.01% |
367,790
+346,420
| +1,621% | +$10.8M |
|
2887
Silgan Holdings
SLGN
$4.49B
| $10.5M | ﹤0.01% |
202,241
-160,375
| -44% | -$8.55M |
|
|
GTM
2888
CALL
ZoomInfo Technologies
GTM
$1.18B
| $10.5M | ﹤0.01% |
1,000,700
-18,000
| -2% | -$192K |
|
|
GTLS
2889
PUT
DELISTED
Chart Industries
GTLS
| $10.5M | ﹤0.01% |
55,100
+21,000
| +62% | +$3.37M |
|
2890
CALL
BridgeBio Pharma
BBIO
$15.6B
| $10.5M | ﹤0.01% |
383,200
+151,700
| +66% | +$3.92M |
|
2891
Myriad Genetics
MYGN
$290M
| $10.5M | ﹤0.01% |
765,241
+697,180
| +1,024% | +$12.9M |
|
2892
CALL
Leidos
LDOS
$18B
| $10.5M | ﹤0.01% |
72,800
+15,100
| +26% | +$2.51M |
|
2893
NextNav
NN
$3.36B
| $10.5M | ﹤0.01% |
673,592
+299,140
| +80% | +$3.98M |
|
|
CNTA
2894
DELISTED
Centessa Pharmaceuticals
CNTA
| $10.5M | ﹤0.01% |
625,316
+37,798
| +6% | +$626K |
|
2895
Kforce
KFRC
$1.04B
| $10.5M | ﹤0.01% |
184,666
-1,290
| -0.7% | -$74.9K |
|
2896
Brookdale Senior Living
BKD
$3.02B
| $10.5M | ﹤0.01% |
2,081,130
-1,110,399
| -35% | -$6.35M |
|
2897
PUT
Axsome Therapeutics
AXSM
$11.2B
| $10.4M | ﹤0.01% |
123,500
+42,700
| +53% | +$3.93M |
|
2898
TriNet
TNET
$3.16B
| $10.4M | ﹤0.01% |
114,945
-119,173
| -51% | -$11M |
|
2899
CALL
iShares Russell 1000 Value ETF
IWD
$84.2B
| $10.4M | ﹤0.01% |
56,300
+28,900
| +105% | +$5.54M |
|
|
OLO
2900
DELISTED
Olo Inc
OLO
| $10.4M | ﹤0.01% |
1,356,577
-576,693
| -30% | -$3.6M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.